cro.directory
← Compare landing

Labcorp vs Pharmaron

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/labcorp/pharmaron

CategoryLabcorpPharmaron
Listed sitecroboth
SummaryGlobal life sciences and healthcare company providing diagnostic testing, drug development services, nonclinical research, and central laboratory services to biopharma companies, healthcare providers, and patients.Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Central Laboratory Services
  • Clinical Operations
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Biomarker Assays
  • Immunogenicity Assays (ADA / NAb)
  • Flow Cytometry Services
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Genetic Toxicology
  • Specialized & Large-Animal Models
  • Translational Research
  • Genomics & Sequencing Services
  • Pathology & Histology Services
  • Companion Diagnostics Development
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Regulatory Affairs
  • Medical Writing
  • Oncology Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • CNS Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • Microbiology Services
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • High-Throughput Screening
  • Target Identification & Validation
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • CMC Analytical Development
  • Process Development
  • Formulation Development
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Flow Chemistry & Continuous Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Cell-Line Development
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Ophthalmic Manufacturing
  • Technology Transfer
  • Quality Control Testing
  • Stability Testing & Storage
  • Extractables & Leachables Studies
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • Cold-Chain Storage & Logistics
  • Combination Product Assembly & Final Packaging
  • CMC Regulatory Submission Support
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Translational Research
  • Companion Diagnostics Development
  • Microbiology Services
  • Virology Services
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Pathology & Histology Services
  • Proteomics Services
  • Genomics & Sequencing Services
  • Bioinformatics & Data Science
  • Device & Combination Product Services
  • Discovery Research
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Radiopharmaceutical
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Peptide
  • Radiopharmaceutical
  • Microbiome Therapeutic
  • AAV / Viral Vector Platform
  • Synthetic Biology
Indications
  • Oncology
  • Neurology
  • Cardiovascular
  • Immunology
  • Infectious Disease
  • Rare Disease
  • Metabolic
  • Respiratory
  • Psychiatry
  • Women's Health
  • Oncology
  • Immunology
  • Neurology
  • Psychiatry
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Gastroenterology
  • Nephrology
  • Women's Health
Locations
  • Global Operations, Global
  • Beijing Headquarters, Beijing, Beijing, China
  • Beijing TSP, Beijing, Beijing, China
  • Beijing Campus II, Beijing, Beijing, China
  • Beijing Campus III, Beijing, Beijing, China
  • Xi'an Chemistry, Xi'an, Shaanxi, China
  • Tianjin Chemical Manufacturing, Tianjin, Tianjin, China
  • Hangzhou AI-Enabled Patient Management, Hangzhou, Zhejiang, China
  • Shanghai Clinical Development, Shanghai, Shanghai, China
  • Shaoxing Commercial API Manufacturing, Shaoxing, Zhejiang, China
  • Ningbo Campus I, Ningbo, Zhejiang, China
  • Ningbo Campus II, Ningbo, Zhejiang, China
  • Ningbo Campus III, Ningbo, Zhejiang, China
  • Nanjing Clinical R&D, Nanjing, Jiangsu, China
  • Qingdao Chemistry, Qingdao, Shandong, China
  • Wuxi Structural Biology & Protein Science, Wuxi, Jiangsu, China
  • Singapore Drug Product Manufacturing, Singapore, Singapore, Singapore
  • Rushden Radiolabelled Chemistry & Metabolism, Rushden, Northamptonshire, United Kingdom
  • Hoddesdon Discovery & Early Development, Hoddesdon, Hertfordshire, United Kingdom
  • Liverpool Gene Therapy CDMO, Liverpool, Merseyside, United Kingdom
  • Cardiff Radiolabelled Chemistry, Cardiff, Wales, United Kingdom
  • Cramlington Commercial API Manufacturing, Cramlington, Northumberland, United Kingdom
  • Louisville Logistics, Louisville, Kentucky, United States
  • Coventry Commercial API Manufacturing, Coventry, West Midlands, United Kingdom
  • San Diego Animal Models, Toxicology, Ocular, Medical Devices, San Diego, California, United States
  • Germantown Clinical Bioanalytical, Germantown, Maryland, United States
  • Boston Biologics, CGT, Boston, Massachusetts, United States
  • Baltimore Clinical Research, Baltimore, Maryland, United States
  • Exton DMPK, Cell and Gene Therapy, Exton, Pennsylvania, United States
  • Headquarters, Beijing, China
  • Operations, China, China
  • Operations, United States, United States
  • Operations, United Kingdom, United Kingdom
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.